ArticleUrolithiasis2025
The effect of narrow costovertebral angle on percutaneous nephrolithotomy outcomes.
Article in Urolithiasis, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Renal Imaging Characteristics Predicting Percutaneous Access for Staghorn Stone Management.Current urology reports · 2026Review
- The effect of narrow costovertebral angle on percutaneous nephrolithotomy outcomes.Urolithiasis · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This study aimed to evaluate the impact of costovertebral angle (CVA) width on the outcomes of percutaneous nephrolithotomy (PCNL), particularly regarding stone-free rates, bleeding, complication rates, and the need for additional interventions. A total of 181 patients who underwent prone PCNL between January 2018 and July 2024 at a single center were retrospectively analyzed. CVA was measured using preoperative standing direct urinary system X-rays. Patients were categorized into three groups based on CVA: <45°, 45-55°, and > 55°. Operative and postoperative parameters including hemoglobin/hematocrit decrease, transfusion requirement, complications (Modified Clavien-Dindo Classification), stone-free rate, and access type were evaluated and statistically analyzed. Hemoglobin and hematocrit decreases were significantly correlated with narrower CVAs (p = 0.041 for both). No significant relationship was observed between CVA and stone-free status, transfusion need, or complication rates. Although patients with CVA < 45° had a higher rate of complications (38.9%) and greater blood loss, these findings did not reach statistical significance. Intercostal access, more frequently required in patients with narrow CVA, was associated with higher but not statistically significant complication rates. Narrow CVA may pose a greater challenge during PCNL due to limited nephroscope maneuverability, potentially increasing intraoperative bleeding. However, it does not significantly affect overall surgical success or complication rates. CVA can be considered a useful anatomical parameter during preoperative planning, especially when selecting the access route.
Indexed as
Identifiers
41428038What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.